On the public citation graph

Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression

https://doi.org/10.1039/d2bm00859a
0 signed · 268 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 200 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-28): 10.1016/j.yexmp.2016.03.012 (notice 2016-04-11).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1520-6017(200005)89:5<652::aid-jps11>3.0.co;2-hopenalex-snapshot
Use of Poly(ethylene glycol)–Lipid Conjugates to Regulate the Surface Attributes and Transfection Activity of Lipid–DNA Particles
inferredcites →https://doi.org/10.1002/(sici)1521-2254(199909/10)1:5<331::aid-jgm60>3.0.co;2-8openalex-snapshot
Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant
inferredcites →https://doi.org/10.1002/adma.201204346openalex-snapshot
Degradable Terpolymers with Alkyl Side Chains Demonstrate Enhanced Gene Delivery Potency and Nanoparticle Stability
inferredcites →https://doi.org/10.1002/adma.201606944openalex-snapshot
Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes
inferredcites →https://doi.org/10.1002/adma.201801151openalex-snapshot
Ionizable Amino‐Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino‐Alcohols for Tissue Selective mRNA Delivery
inferredcites →https://doi.org/10.1002/adma.201805116openalex-snapshot
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
inferredcites →https://doi.org/10.1002/adma.201805308openalex-snapshot
Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
inferredcites →https://doi.org/10.1002/adma.201807748openalex-snapshot
Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant Doses
inferredcites →https://doi.org/10.1002/adma.202004452openalex-snapshot
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
inferredcites →https://doi.org/10.1002/adma.202006619openalex-snapshot
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
inferredcites →https://doi.org/10.1002/adma.202101707openalex-snapshot
Secreted Expression of mRNA‐Encoded Truncated ACE2 Variants for SARS‐CoV‐2 via Lipid‐Like Nanoassemblies
inferredcites →https://doi.org/10.1002/anie.201203263openalex-snapshot
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
inferredcites →https://doi.org/10.1002/anie.201603648openalex-snapshot
A Single Methylene Group in Oligoalkylamine‐Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery
inferredcites →https://doi.org/10.1002/anie.201608450openalex-snapshot
Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
inferredcites →https://doi.org/10.1002/anie.201610209openalex-snapshot
Non‐Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co‐Delivery of Cas9 mRNA and sgRNA
inferredcites →https://doi.org/10.1002/anie.201809056openalex-snapshot
Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
inferredcites →https://doi.org/10.1002/eji.1830230749openalex-snapshot
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
inferredcites →https://doi.org/10.1002/eji.200737984openalex-snapshot
Nanoparticles target distinct dendritic cell populations according to their size
inferredcites →https://doi.org/10.1002/hep.27406openalex-snapshot
The global burden of liver disease: The major impact of China
inferredcites →https://doi.org/10.1002/jcph.1553openalex-snapshot
Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
inferredcites →https://doi.org/10.1002/smll.201805097openalex-snapshot
Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH
inferredcites →https://doi.org/10.1002/wrna.15openalex-snapshot
Regulation of mRNA decapping
inferredcites →https://doi.org/10.1006/mthe.1999.0021openalex-snapshot
Aerosol Delivery of Robust Polyethyleneimine– DNA Complexes for Gene Therapy and Genetic Immunization
inferredcites →https://doi.org/10.1006/mthe.2002.0698openalex-snapshot
Deposition and Expression of Aerosolized rAAV Vectors in the Lungs of Rhesus Macaques
inferredcites →https://doi.org/10.1007/978-1-4939-6588-5_10openalex-snapshot
Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents
inferredcites →https://doi.org/10.1007/bf00210403openalex-snapshot
Molecular basis of phenotypic variation in patients with argininemia
inferredcites →https://doi.org/10.1007/s12195-019-00573-4openalex-snapshot
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
inferredcites →https://doi.org/10.1016/j.actbio.2019.11.022openalex-snapshot
Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles
inferredcites →https://doi.org/10.1016/j.addr.2008.09.011openalex-snapshot
Extracellular barriers in respiratory gene therapy
inferredcites →https://doi.org/10.1016/j.addr.2016.01.022openalex-snapshot
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
inferredcites →https://doi.org/10.1016/j.addr.2017.08.010openalex-snapshot
PEGylation for enhancing nanoparticle diffusion in mucus
inferredcites →https://doi.org/10.1016/j.addr.2020.06.026openalex-snapshot
Lipid nanoparticle technology for therapeutic gene regulation in the liver
inferredcites →https://doi.org/10.1016/j.bbrc.2005.12.105openalex-snapshot
mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level
inferredcites →https://doi.org/10.1016/j.bbrc.2018.12.137openalex-snapshot
Dendritic targeted mRNA expression via a cis-acting RNA UTR element
inferredcites →https://doi.org/10.1016/j.biocel.2019.105562openalex-snapshot
Lymphatic and blood systems: Identical or fraternal twins?
inferredcites →https://doi.org/10.1016/j.biomaterials.2008.12.076openalex-snapshot
The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles
inferredcites →https://doi.org/10.1016/j.biomaterials.2016.09.006openalex-snapshot
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
inferredcites →https://doi.org/10.1016/j.biomaterials.2021.120966openalex-snapshot
Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles
inferredcites →https://doi.org/10.1016/j.celrep.2017.11.081openalex-snapshot
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
inferredcites →https://doi.org/10.1016/j.celrep.2018.02.014openalex-snapshot
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
inferredcites →https://doi.org/10.1016/j.cld.2016.08.001openalex-snapshot
Drug Metabolism in the Liver
inferredcites →https://doi.org/10.1016/j.clinre.2011.05.016openalex-snapshot
Gene therapy of liver diseases: A 2011 perspective
inferredcites →https://doi.org/10.1016/j.ebiom.2019.07.003openalex-snapshot
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
inferredcites →https://doi.org/10.1016/j.ejpb.2013.07.002openalex-snapshot
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
inferredcites →https://doi.org/10.1016/j.ijpharm.2011.07.013openalex-snapshot
Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
inferredcites →https://doi.org/10.1016/j.ijpharm.2021.120586openalex-snapshot
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
inferredcites →https://doi.org/10.1016/j.immuni.2005.06.008openalex-snapshot
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
inferredcites →https://doi.org/10.1016/j.jconrel.2005.06.014openalex-snapshot
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
inferredcites →https://doi.org/10.1016/j.jconrel.2006.01.006openalex-snapshot
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
inferredcites →https://doi.org/10.1016/j.jconrel.2011.09.098openalex-snapshot
The journey of a drug-carrier in the body: An anatomo-physiological perspective
inferredcites →https://doi.org/10.1016/j.jconrel.2012.09.009openalex-snapshot
A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo
inferredcites →https://doi.org/10.1016/j.jconrel.2016.02.043openalex-snapshot
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
inferredcites →https://doi.org/10.1016/j.jconrel.2016.05.059openalex-snapshot
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
inferredcites →https://doi.org/10.1016/j.jconrel.2016.06.001openalex-snapshot
Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles
inferredcites →https://doi.org/10.1016/j.jconrel.2017.09.044openalex-snapshot
Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus
inferredcites →https://doi.org/10.1016/j.jconrel.2018.10.015openalex-snapshot
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
inferredcites →https://doi.org/10.1016/j.jconrel.2019.04.015openalex-snapshot
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
inferredcites →https://doi.org/10.1016/j.jconrel.2019.06.042openalex-snapshot
Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration
inferredcites →https://doi.org/10.1016/j.jconrel.2021.11.022openalex-snapshot
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
inferredcites →https://doi.org/10.1016/j.jconrel.2022.03.046openalex-snapshot
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
inferredcites →https://doi.org/10.1016/j.jhep.2016.07.009openalex-snapshot
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
inferredcites →https://doi.org/10.1016/j.jhep.2018.09.014openalex-snapshot
Burden of liver diseases in the world
inferredcites →https://doi.org/10.1016/j.nantod.2015.06.006openalex-snapshot
Nanoparticle uptake: The phagocyte problem
inferredcites →https://doi.org/10.1016/j.nantod.2015.09.003openalex-snapshot
RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications
inferredcites →https://doi.org/10.1016/j.neuron.2018.03.030openalex-snapshot
Alternative 3′ UTRs Modify the Localization, Regulatory Potential, Stability, and Plasticity of mRNAs in Neuronal Compartments
inferredcites →https://doi.org/10.1016/j.omtm.2018.04.003openalex-snapshot
Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
inferredcites →https://doi.org/10.1016/j.omtn.2017.04.006openalex-snapshot
Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
inferredcites →https://doi.org/10.1016/j.progpolymsci.2010.04.007openalex-snapshot
Hydrophobic modifications of cationic polymers for gene delivery
inferredcites →https://doi.org/10.1016/j.vaccine.2004.06.028openalex-snapshot
Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells
inferredcites →https://doi.org/10.1016/j.yexmp.2016.03.012openalex-snapshot
RETRACTED: Endothelial PECAM-1 and its function in vascular physiology and atherogenic pathology
inferredcites →https://doi.org/10.1016/j.ymeth.2003.11.023openalex-snapshot
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications
inferredcites →https://doi.org/10.1016/j.ymthe.2017.03.013openalex-snapshot
Lipid Nanoparticle Systems for Enabling Gene Therapies
inferredcites →https://doi.org/10.1016/j.ymthe.2017.03.016openalex-snapshot
Optimizing Cardiac Delivery of Modified mRNA
inferredcites →https://doi.org/10.1016/j.ymthe.2017.12.024openalex-snapshot
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
inferredcites →https://doi.org/10.1016/j.ymthe.2018.01.006openalex-snapshot
G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a
inferredcites →https://doi.org/10.1016/j.ymthe.2018.03.010openalex-snapshot
A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
inferredcites →https://doi.org/10.1016/j.ymthe.2018.05.014openalex-snapshot
Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
inferredcites →https://doi.org/10.1016/j.ymthe.2018.11.018openalex-snapshot
mRNA-Based Protein Replacement Therapy for the Heart
inferredcites →https://doi.org/10.1016/j.ymthe.2019.02.012openalex-snapshot
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
inferredcites →https://doi.org/10.1016/j.ymthe.2019.02.019openalex-snapshot
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
inferredcites →https://doi.org/10.1016/j.ymthe.2019.05.012openalex-snapshot
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
inferredcites →https://doi.org/10.1016/j.ymthe.2020.06.015openalex-snapshot
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
inferredcites →https://doi.org/10.1016/j.ymthe.2021.06.004openalex-snapshot
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
inferredcites →https://doi.org/10.1016/s0021-9258(18)47945-8openalex-snapshot
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.
inferredcites →https://doi.org/10.1016/s0300-9084(02)01445-1openalex-snapshot
mRNA degradation machines in eukaryotic cells
inferredcites →https://doi.org/10.1016/s0735-1097(00)01144-xopenalex-snapshot
Efficacy of intracoronary or intravenous VEGF165in a pig model of chronic myocardial ischemia
inferredcites →https://doi.org/10.1016/s1569-1993(21)02006-3openalex-snapshot
583: Variant-agnostic CFTR rescue using aerosolized delivery of CFTR mRNA using the SORT-LNP in primary human bronchial epithelial cells derived from patients with cystic fibrosis
inferredcites →https://doi.org/10.1016/s2213-2600(20)30105-3openalex-snapshot
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
inferredcites →https://doi.org/10.1021/acs.accounts.1c00521openalex-snapshot
Immunogenicity of In Vitro -Transcribed RNA
inferredcites →https://doi.org/10.1021/acs.biomac.5b00795openalex-snapshot
Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells
inferredcites →https://doi.org/10.1021/acs.biomac.6b00900openalex-snapshot
Mapping Optimal Charge Density and Length of ROMP-Based PTDMs for siRNA Internalization
inferredcites →https://doi.org/10.1021/acs.biomac.7b01356openalex-snapshot
Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers
inferredcites →https://doi.org/10.1021/acs.chemrev.1c00244openalex-snapshot
Lipids and Lipid Derivatives for RNA Delivery
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b01084openalex-snapshot
In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration
inferredcites →https://doi.org/10.1021/acs.nanolett.0c00596openalex-snapshot
A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
inferredcites →https://doi.org/10.1021/acs.nanolett.0c01386openalex-snapshot
Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
inferredcites →https://doi.org/10.1021/acs.nanolett.5b02428openalex-snapshot
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
inferredcites →https://doi.org/10.1021/acs.nanolett.5b02497openalex-snapshot
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
inferredcites →https://doi.org/10.1021/acs.nanolett.6b03329openalex-snapshot
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
inferredcites →https://doi.org/10.1021/acs.nanolett.8b02917openalex-snapshot
Optimization of a Degradable Polymer–Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells
inferredcites →https://doi.org/10.1021/acs.nanolett.8b03149openalex-snapshot
Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo
inferredcites →https://doi.org/10.1021/acs.nanolett.9b04246openalex-snapshot
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
inferredcites →https://doi.org/10.1021/acsami.1c14975openalex-snapshot
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
inferredcites →https://doi.org/10.1021/acsbiomaterials.8b01062openalex-snapshot
Nanomaterial Interactions with Human Neutrophils
inferredcites →https://doi.org/10.1021/acsnano.8b03640openalex-snapshot
Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery
inferredcites →https://doi.org/10.1021/bi00018a025openalex-snapshot
Transbilayer Movement and Net Flux of Cholesterol and Cholesterol Sulfate between Liposomal Membranes
inferredcites →https://doi.org/10.1021/ja505986aopenalex-snapshot
Multivalent N -Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
inferredcites →https://doi.org/10.1021/jacs.1c09822openalex-snapshot
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
inferredcites →https://doi.org/10.1021/la104590kopenalex-snapshot
Ionization Behavior of Amino Lipids for siRNA Delivery: Determination of Ionization Constants, SAR, and the Impact of Lipid pKa on Cationic Lipid−Biomembrane Interactions
inferredcites →https://doi.org/10.1021/mp400140uopenalex-snapshot
Stabilization of Distearoylphosphatidylcholine Lamellar Phases in Propylene Glycol Using Cholesterol
inferredcites →https://doi.org/10.1021/nn406018qopenalex-snapshot
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
inferredcites →https://doi.org/10.1038/cr.2013.112openalex-snapshot
Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA
inferredcites →https://doi.org/10.1038/cr.2017.16openalex-snapshot
A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo
inferredcites →https://doi.org/10.1038/d41586-021-02483-wopenalex-snapshot
The tangled history of mRNA vaccines
inferredcites →https://doi.org/10.1038/emboj.2011.286openalex-snapshot
Endosome maturation
inferredcites →https://doi.org/10.1038/gt.2011.17openalex-snapshot
Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
inferredcites →https://doi.org/10.1038/gt.2011.55openalex-snapshot
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung
inferredcites →https://doi.org/10.1038/gt.2015.68openalex-snapshot
Efficient expression of stabilized mRNA PEG-peptide polyplexes in liver
inferredcites →https://doi.org/10.1038/gt.2016.46openalex-snapshot
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
inferredcites →https://doi.org/10.1038/mt.2008.200openalex-snapshot
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
inferredcites →https://doi.org/10.1038/mt.2009.70openalex-snapshot
VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial
inferredcites →https://doi.org/10.1038/mt.2010.85openalex-snapshot
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
inferredcites →https://doi.org/10.1038/mt.2013.124openalex-snapshot
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
inferredcites →https://doi.org/10.1038/mt.2013.49openalex-snapshot
Adenoviral Gene Transfer Corrects the Ion Transport Defect in the Sinus Epithelia of a Porcine CF Model
inferredcites →https://doi.org/10.1038/mt.2015.103openalex-snapshot
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
inferredcites →https://doi.org/10.1038/mt.2015.193openalex-snapshot
Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression
inferredcites →https://doi.org/10.1038/mtna.2013.65openalex-snapshot
Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
inferredcites →https://doi.org/10.1038/natrevmats.2017.56openalex-snapshot
Tools for translation: non-viral materials for therapeutic mRNA delivery
inferredcites →https://doi.org/10.1038/nature18300openalex-snapshot
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
inferredcites →https://doi.org/10.1038/nature23003openalex-snapshot
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
inferredcites →https://doi.org/10.1038/nbt.2682openalex-snapshot
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
inferredcites →https://doi.org/10.1038/nbt.3802openalex-snapshot
Overcoming cellular barriers for RNA therapeutics
inferredcites →https://doi.org/10.1038/nbt.4005openalex-snapshot
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
inferredcites →https://doi.org/10.1038/nbt1372openalex-snapshot
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state
inferredcites →https://doi.org/10.1038/ncomms14630openalex-snapshot
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
inferredcites →https://doi.org/10.1038/ncomms5277openalex-snapshot
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
inferredcites →https://doi.org/10.1038/ng0992-21openalex-snapshot
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
inferredcites →https://doi.org/10.1038/nm.4356openalex-snapshot
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
inferredcites →https://doi.org/10.1038/nmat3187openalex-snapshot
Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery
inferredcites →https://doi.org/10.1038/nmat4718openalex-snapshot
Mechanism of hard-nanomaterial clearance by the liver
inferredcites →https://doi.org/10.1038/nrd.2018.93openalex-snapshot
Principles for targeting RNA with drug-like small molecules
inferredcites →https://doi.org/10.1038/nrd4278openalex-snapshot
mRNA-based therapeutics — developing a new class of drugs
inferredcites →https://doi.org/10.1038/nrd892openalex-snapshot
The druggable genome
inferredcites →https://doi.org/10.1038/nrm2336openalex-snapshot
Cellular cholesterol trafficking and compartmentalization
inferredcites →https://doi.org/10.1038/onc.2009.211openalex-snapshot
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
inferredcites →https://doi.org/10.1038/s41423-020-0488-6openalex-snapshot
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
inferredcites →https://doi.org/10.1038/s41467-018-06936-1openalex-snapshot
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
inferredcites →https://doi.org/10.1038/s41467-020-14527-2openalex-snapshot
Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA
inferredcites →https://doi.org/10.1038/s41467-020-16248-yopenalex-snapshot
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
inferredcites →https://doi.org/10.1038/s41467-020-17029-3openalex-snapshot
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
inferredcites →https://doi.org/10.1038/s41467-020-19156-3openalex-snapshot
Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia
inferredcites →https://doi.org/10.1038/s41467-021-23318-2openalex-snapshot
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
inferredcites →https://doi.org/10.1038/s41467-021-23546-6openalex-snapshot
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
inferredcites →https://doi.org/10.1038/s41551-019-0378-3openalex-snapshot
Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging
inferredcites →https://doi.org/10.1038/s41551-021-00786-xopenalex-snapshot
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
inferredcites →https://doi.org/10.1038/s41551-021-00794-xopenalex-snapshot
Lipid nanoparticles for the inhalation of mRNA
inferredcites →https://doi.org/10.1038/s41563-020-00886-0openalex-snapshot
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
inferredcites →https://doi.org/10.1038/s41565-018-0358-xopenalex-snapshot
Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
inferredcites →https://doi.org/10.1038/s41565-019-0591-yopenalex-snapshot
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
inferredcites →https://doi.org/10.1038/s41565-020-0669-6openalex-snapshot
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
inferredcites →https://doi.org/10.1038/s41565-021-00898-0openalex-snapshot
The current landscape of nucleic acid therapeutics
inferredcites →https://doi.org/10.1038/s41565-022-01071-xopenalex-snapshot
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
inferredcites →https://doi.org/10.1038/s41569-018-0036-6openalex-snapshot
Therapeutic approaches for cardiac regeneration and repair
inferredcites →https://doi.org/10.1038/s41576-021-00439-4openalex-snapshot
Drug delivery systems for RNA therapeutics
inferredcites →https://doi.org/10.1038/s41578-021-00358-0openalex-snapshot
Lipid nanoparticles for mRNA delivery
inferredcites →https://doi.org/10.1038/s41586-020-2537-9openalex-snapshot
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
inferredcites →https://doi.org/10.1038/s41587-019-0015-4openalex-snapshot
Antigen-specific therapeutic approaches for autoimmunity
inferredcites →https://doi.org/10.1038/s41587-021-00822-wopenalex-snapshot
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
inferredcites →https://doi.org/10.1038/s41591-018-0199-zopenalex-snapshot
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
inferredcites →https://doi.org/10.1038/s41598-018-26298-4openalex-snapshot
mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
inferredcites →https://doi.org/10.1038/s41598-018-34960-0openalex-snapshot
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
inferredcites →https://doi.org/10.1038/s41598-019-49028-wopenalex-snapshot
Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice
inferredcites →https://doi.org/10.1038/s41598-020-64017-0openalex-snapshot
Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency
inferredcites →https://doi.org/10.1038/s41598-020-75253-9openalex-snapshot
Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening
inferredcites →https://doi.org/10.1038/sj.gt.3301525openalex-snapshot
Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium
inferredcites →https://doi.org/10.1038/sj.gt.3301663openalex-snapshot
Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus
inferredcites →https://doi.org/10.1038/srep15810openalex-snapshot
Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases
inferredcites →https://doi.org/10.1038/srep20019openalex-snapshot
Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia
inferredcites →https://doi.org/10.1039/d0bm01609hopenalex-snapshot
Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver
inferredcites →https://doi.org/10.1039/d0bm01947jopenalex-snapshot
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
inferredcites →https://doi.org/10.1039/d1bm01454dopenalex-snapshot
Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)
inferredcites →https://doi.org/10.1056/nejmoa2107454openalex-snapshot
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
inferredcites →https://doi.org/10.1073/pnas.0910603106openalex-snapshot
Lipid-like materials for low-dose, in vivo gene silencing
inferredcites →https://doi.org/10.1073/pnas.1520756113openalex-snapshot
Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model
inferredcites →https://doi.org/10.1073/pnas.1619653114openalex-snapshot
Systemic delivery of factor IX messenger RNA for protein replacement therapy
inferredcites →https://doi.org/10.1073/pnas.1805358115openalex-snapshot
Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
inferredcites →https://doi.org/10.1073/pnas.1811276115openalex-snapshot
High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing
inferredcites →https://doi.org/10.1073/pnas.1906182116openalex-snapshot
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
inferredcites →https://doi.org/10.1073/pnas.1912012117openalex-snapshot
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
inferredcites →https://doi.org/10.1073/pnas.2020401118openalex-snapshot
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
inferredcites →https://doi.org/10.1073/pnas.2109256118openalex-snapshot
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
inferredcites →https://doi.org/10.1073/pnas.86.16.6077openalex-snapshot
Cationic liposome-mediated RNA transfection.
inferredcites →https://doi.org/10.1074/jbc.m309026200openalex-snapshot
Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport
inferredcites →https://doi.org/10.1080/17476348.2019.1634547openalex-snapshot
Emerging gene therapies for cystic fibrosis
inferredcites →https://doi.org/10.1089/hum.2006.17.1openalex-snapshot
Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications
inferredcites →https://doi.org/10.1089/hum.2006.17.1027openalex-snapshot
Synthetic Messenger RNA as a Tool for Gene Therapy
inferredcites →https://doi.org/10.1089/hum.2020.137openalex-snapshot
Treating Cystic Fibrosis with mRNA and CRISPR
inferredcites →https://doi.org/10.1089/jop.2012.0138openalex-snapshot
The Vitreous Humor As a Barrier to Nanoparticle Distribution
inferredcites →https://doi.org/10.1089/nat.2018.0734openalex-snapshot
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
inferredcites →https://doi.org/10.1097/icu.0000000000000660openalex-snapshot
Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease
showing the first 200 of 249 · page through all 249

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4657914openalex-extracted
Delivery of Rna Drugs: Beyond the Liver, More than Vaccine
inferred← citeshttps://doi.org/10.1002/9781394300150.ch6openalex-snapshot
mRNA‐Based Vaccines and Therapeutics
inferred← citeshttps://doi.org/10.1002/ange.3823572openalex-snapshot
Retinoic‐Acid‐Derived Ionizable Lipids Enable Spleen‐Selective Antigen Expression for mRNA Cancer Vaccination
inferred← citeshttps://doi.org/10.1002/anie.3823572openalex-snapshot
Retinoic‐Acid‐Derived Ionizable Lipids Enable Spleen‐Selective Antigen Expression for mRNA Cancer Vaccination
inferred← citeshttps://doi.org/10.1002/mba2.70036openalex-snapshot
Investigations Into the Influence of Ionizable Lipids on the Stability of Lipid Nanoparticle
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2024.122853openalex-snapshot
Pharmaceutical strategies for optimized mRNA expression
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114203openalex-snapshot
Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine
inferred← citeshttps://doi.org/10.1016/j.molmed.2023.03.001openalex-snapshot
Recent insights into lysosomal acid lipase deficiency
inferred← citeshttps://doi.org/10.1016/j.ymthe.2025.06.018openalex-snapshot
Therapeutic effect of galactosyltransferase- and sialyltransferase-encoding mRNA in rheumatoid arthritis
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00774openalex-snapshot
mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications
inferred← citeshttps://doi.org/10.1021/acsami.4c11819openalex-snapshot
Gastrointestinal Device-Mediated Delivery of mRNA-Lipid Nanoparticles Achieves Distinct Expression and Biodistribution in Mice and Pigs
inferred← citeshttps://doi.org/10.1038/s41573-023-00859-3openalex-snapshot
Strategies to reduce the risks of mRNA drug and vaccine toxicity
inferred← citeshttps://doi.org/10.1039/d5bm00322aopenalex-snapshot
Non-viral mRNA delivery to the lungs
inferred← citeshttps://doi.org/10.1101/2024.12.07.627318openalex-snapshot
Lipid-based nanoparticles deliver mRNA to reverse the pathogenesis of lysosomal acid lipase deficiency in a preclinical model
inferred← citeshttps://doi.org/10.2147/cpaa.s418314openalex-snapshot
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
inferred← citeshttps://doi.org/10.3390/vaccines13040370openalex-snapshot
Mind the Age Gap: Expanding the Age Window for mRNA Vaccine Testing in Mice
inferred← citeshttps://doi.org/10.37349/eemd.2024.00011openalex-snapshot
Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
inferred← citeshttps://doi.org/10.47570/joci.2024.004openalex-snapshot
Beyond the injection site: identifying the cellular targets of mRNA vaccines
inferred← citeshttps://doi.org/10.7150/thno.90071openalex-snapshot
Quaternization drives spleen-to-lung tropism conversion for mRNA-loaded lipid-like nanoassemblies
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.